A review of Motivational Interviewing to enhance adherence to antipsychotic medication in patients with schizophrenia: Evidence and recommendations

Journal of Mental Health

Volumn 18, Issue 1, 2009, Pages 6-15

  Drymalski, Walter M ^a,b   Campbell, Todd C ^a  

^a MARQUETTE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Adherence; Antipsychotics; Motivational Interviewing

Indexed keywords

EID: 61649092630     PISSN: 09638237     EISSN: 13600567     Source Type: Journal    
DOI: 10.1080/09638230802052161     Document Type: Review

References (54)

1. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
2. Ascher-Svanum, H., Faries, D.E., Zhu, B., Ernst, F.R., Swartz, M.S., & Swanson, J.W. (2006). Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. Journal of Clinical Psychiatry, 67, 453-460.
3. Baer, J.S., Rosengren, D.B., Dunn, C.W., Wells, E.A., Ogle, R. L., & Hartzler, B. (2004). An evaluation of workshop training in motivational interviewing for addiction and mental health clinicians. Drug and Alcohol Dependence, 73, 99-106.
4. Bollini, P., Tibaldi, G., Testa, C., & Munizza, C. (2004). Understanding treatment adherence in affective disorders: A qualitative study. Journal of Psychiatric and Mental Health Nursing, 11, 668-674.
5. Britt, E., Hudson, S.M., & Blampied, N.M. (2004). Motivational interviewing in health settings: A review. Patient Education and Counseling, 53, 147-155.
6. Burke, B.L., Arkowitz, H., & Menchola, M. (2003). The efficacy of motivational interviewing: A meta-analysis of controlled clinical trials. Journal of Consulting and Clinical Psychology, 71, 843-861.
7. Byerly, M.J., Fisher, R., Carmody, T., & Rush, A.J. (2005). A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry, 66, 997-1001.
8. Byerly, M.J., Nakonezny, P.A., & Lescouflair, E. (2007). Antipsychotic medication adherence in schizophrenia. Psychiatric Clinics of North America, 30, 437-452.
9. Cantrell, C.R., Eaddy, M.T., Shah, M.B., Regan, T.S., & Sokol, M.C. (2006). Methods for evaluating patient adherence to antidepressant therapy: A real-world comparison of adherence and economic outcomes. Medical Care, 44, 300-303.
10. Chanut, F., Brown, T.G., & Dongier, M. (2005). Motivational interviewing and clinical psychiatry. Canadian Journal of Psychiatry, 50, 715-721.
11. Conley, R.R., Ascher-Svanum, H., Zhu, B., & Faries, D.E., & Kinon, B.J. (2007). The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophrenia Research, 90, 186-197.
12. Corrigan, P.W., McCracken, S.G., & Holmes, E.P. (2001). Motivational interviewing as goal assessment for persons with psychiatric disability. Community Mental Health Journal, 37, 113-122.
13. DiMatteo, M.R., Giordani, P.J., Lepper, H.S., & Croghan, T.W. (2002). Patient adherence and medical treatment outcomes: A meta-analysis. Medical Care, 40, 794-811.
14. DiMatteo, M.R. (2004). Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care, 42, 200-209.
15. Drake, R.E., Mueser, K.T., Brunette, M.F., & McHugo, G.J. (2004). A review of treatment for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal, 27, 360-374.
16. Dunn, C., DeRoo, L., & Rivara, F.P. (2001). The use of brief interventions adapted from motivational interviewing across behavioral domains: A systematic review. Addiction, 96, 1725-1742.
17. Elbogen, E.B., Swanson, J.W., Swartz, M.S., & Van Dorn, R. (2005). Medication nonadherence and substance abuse in psychotic disorders: Impact of depressive symptoms and social stability. Journal of Nervous and Mental Disorders, 193, 673-679.
18. Freudenreich, O., Cather, C., Evins, A.E., Henderson, D.C., & Goff, D.C. (2004). Attitudes of schizophrenia outpatients towards psychiatric medications: Relationship to clinical variables and insight. Journal of Clinical Psychiatry, 65, 1372-1376.
19. Gilmer, T.P., Dolder, C.R., Lacro, J.P., Folsom, D.P., Lindamer, L., & Garcia, P., et al. (2004). Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry, 161, 692-699.
20. Gray, R., Wykes, T., & Gournay, K. (2002). From compliance to concordance: A review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing, 9, 277-284.
21. Hayward, P., Chan, N., Kemp, R., Youle, & David, A. (1995). Medication of self-management: A preliminary report on an intervention to improve medication compliance. Journal of Mental Health, 4, 511-517.
22. Haynes, R.B., Yao, X., Degani, A., Kripalani, S., Garg, A., & McDonald, H.P. (2005). Interventions for enhancing medication adherence. Retrieved 23 May 2006 from the Cochrane Database of Systematic Reviews: http// CD000011. DOI: 10.1002/14651858.CD000011.pub2.
23. Katon, W., Von Korff, M., Lin, E., Walker, E., Simon, G.E., & Bush, T., et al. (1995). Collaborative management to achieve treatment guidelines. Impact on depression in primary care. Journal of the American Medical Association, 273, 1026-1031.
24. Kemp, R., Hayward, P., Applewhaite, G., Everitt, B., & David, A. (1996). Compliance therapy in psychotic patients: Randomised controlled trial. British Medical Journal, 312, 345-349.
25. Kemp, R., Kirov, G. Everitt, B., Hayward, P., & David, A. (1998). Randomised controlled trial of compliance therapy. British Journal of Psychiatry, 172, 413-419.
26. Lacro, J.P., Dunn, L.B., Dolder, C.R., Leckband, S.G., & Jeste, D.V. (2002). Prevalence of and risk factors for medication non-adherence in patients with schizophrenia: A comprehensive review of recent literature. Journal of Clinical Psychiatry, 63, 892-909.
27. Liu-Seifert, H., Adams, D.H., & Kinon, B.J. (2005). Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: A pooled post-hoc analysis of four atypical antipsychotic drugs. Retrieved 20 April 2006 from: http://www.biomedcentral.com/1741-7015/3/21
28. Loffler, W., Kilian, R., Toumi, M., & Angermeyer, M.C. (2003). Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry, 36, 105-112.
29. Longo, L. (2006, May). Psychopharmacology and the neurobiology of addiction. Presentation at the 40th annual spring conference of the Wisconsin Association on Alcohol and Other Drug Abuse, Madison, WI.
30. Madson, M.B., & Campbell, T.C. (2006). Measures of fidelity in motivational enhancement: A systematic review. Journal of Substance Abuse Treatment, 31, 67-73.
31. Madson, M.B., Campbell, T.C., Barrett, D.E., Brondino, M.J., & Melchert, T.P. (2005). Development of the Motivational Interviewing Supervision and Training Scale. Psychology of Addictive Behaviors, 19, 303-310.
32. Marder, S.R. (2003). Overview of partial compliance. Journal of Clinical Psychiatry, 64(Suppl. 16), 3-9.
33. Martino, S., Carroll, K.M., O'Malley, S.S., & Rounsaville, B.J. (2000). Motivational interviewing with psychiatrically ill substance abusing patients. The American Journal on Addictions, 9, 88-91.
34. Miller, W.R., & Rollnick, S. (1991). Motivational interviewing: Preparing people to change addictive behavior. New York: Guilford Press.
35. Miller, W.R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change. New York: Guilford Press.
36. Miller, W.R., Yahne, C.E., Moyers, T.B., Martinez, J., & Pirritano, M. (2004). A randomized trial of methods to help clinicians learn motivational interviewing. Journal of Consulting and Clinical Psychology, 72, 1050-1062.
37. Mojtabai, R., & Olfson, M. (2003). Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Affairs, 22, 220-229.
38. Moyers, T.B., Miller, W.R., & Hendrickson, S.M.L. (2005). How does motivational interviewing work? Therapist interpersonal skill predicts client involvement within motivational interviewing sessions. Journal of Consulting and Clinical Psychology, 73, 590-598.
39. Moyers, T.B., & Rollnick, S. (2002). A motivational interviewing perspective on resistance in psychotherapy. Journal of Clinical Psychology, 58, 185-193.
40. O'Donnell, C., Donohoe, G., Sharkey, L., Owens, N., Migone, M., & Harries, R., et al. (2003). Compliance therapy: A randomized controlled trial in schizophrenia. British Medical Journal, 327, 834-837.
41. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. The New England Journal of Medicine, 353, 487-497.
42. Rounsaville, B.J., Carroll, K.M., & Onken, L.S. (2001). A stage model of behavioral therapy research: Getting started and moving on from stage I. Clinical Psychology: Science and Practice, 8, 133-142.
43. Rubak, S., Sandboek, A., Lauritzen, T., & Christensen, B. (2005). Motivational interviewing: A systematic review and meta-analysis. The British Journal of General Practice, 55, 305-312.
44. Rusch, N., & Corrigan, P.W. (2002). Motivational interviewing to improve insight and treatment adherence in schizophrenia. Psychiatric Rehabilitation Journal, 26, 23-32.
45. Sokol, M.C., McGuigan, K.A., Verbrugge, R.R., & Epstein, R.S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 43, 521-530.
46. Swanson, A.J., Pantalon, M.V., & Cohen, K.R. (1999). Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease, 187, 630-635.
47. Theida, P., Beard, S., Richter, A., & Kane, J. (2003). An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatric Services, 54, 508-516.
48. Vasilaki, E.I., Hosier, S.G., & Cox, M. (2006). The efficacy of motivational interviewing as a brief intervention for excessive drinking: A meta-analytic review. Alcohol & Alcoholism, 41, 328-335.
49. Velligan, D.I., Lam, Y.W.F., Glahn, D.C., Barrett, J.A., Maples, N.J., & Ereshefsky, L., et al. (2007). Defining and assessing adherence to oral antipsychotics: A review of the literature. Schizophrenia Bulletin, 32, 724-742.
50. Vergouwen, A.C.M., Bakker, A., Katon, W.J., Verheij, T.J., & Koerselman, F. (2003). Improving adherence to antidepressants: A systematic review of interventions. Journal of Clinical Psychiatry, 64, 1415-1420.
51. Weiden, P.J., Kozma, C., Grogg, A., & Locklear, J. (2004). Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services, 55, 886-891.
52. Westra, H.A. (2004). Managing resistance in cognitive behavioural therapy: The application of motivational interviewing in mixed anxiety and depression. Cognitive Behaviour Therapy, 33, 161-175.
53. Wu, E.Q., Birnbaum, H.G., Shi, L., Ball, D.E., Kessler, R.C., & Moulis, M., et al. (2005). The economic burden of schizophrenia in the United States in 2002. Journal of Clinical Psychiatry, 66, 1122-1129.
54. Zygmunt, A., Offson, M., Boyer, C.A., & Mechanic, D. (2002). Interventions to improve medication adherence to schizophrenia. American Journal of Psychiatry, 59, 1653-1664.